New Tool: ProSource
Checkout our packaging and processing solutions finder, ProSource.
Start Your Search

There’s a Promising New HIV Vaccine in Trials

The vaccine could be the first of a multi-step vaccine strategy to defeat HIV.

A recent European Pharmaceutical Review article discussed a novel HIV vaccine that has shown promise in its first human Phase I trial. The vaccine is in development to become a primer that activates B cells through germline-targeting. The hope is that these specialized blood proteins could adhere to the HIV surface proteins that allow the virus to enter human cells, and disable them.

The Phase 1 human trial is considered a “landmark study” in the HIV vaccine field as it successfully primed the immune response to fight HIV-1. The strategy can also be applied to other pathogens in that it can efficiently stimulate rare immune cells that have specific properties.

Discover Our Content Hub
Access Healthcare Packaging's free educational content library!
Unlock Learning Here
Discover Our Content Hub
Test Your Supply Chain Smarts
Take Healthcare Packaging's supply chain quiz to prove your knowledge!
Take Quiz
Test Your Supply Chain Smarts